Reverse MIC drift of nemonoxacin and its advantages against Gram-positive bacteria: A 10-year multicenter surveillance study
Background: Antimicrobial resistance (AMR) threatens global health. Conventional fluoroquinolones have experienced accelerated resistance due to target‑enzyme mutations and are further constrained by safety concerns. Nemonoxacin, as the first non‑fluorinated quinolone, overcomes the aforementioned d...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
KeAi Communications Co., Ltd.
2026-03-01
|
| Serie: | Precision Medication |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2950523226000102 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|